The Environmental Protection Agency (EPA) has delayed holding hearings relating to the carcinogenicity of glyphosate for two months. Now, December 13 through the 16, 2016, after a public comment period, a Federal Insecticide, Fungicide and Rodenticide Act Scientific Advisory Panel will advise the EPA on how to evaluate relevant data and make a carcinogenic risk classification for glyphosate.
Glyphosate is the key ingredient in Monsanto’s Roundup® and many other pesticides and the key to the success of Monsanto’s genetically modified (GMO) Roundup®-tolerant crops. In 2015, independent international cancer scientists from the World Health Organization (WHO) classified glyphosate as a probable human carcinogen. While Monsanto attached the credibility of this classification, Dr. Kurt Straif, a section head of the WHO’s International Agency for Research on Cancer (IARC), defended the assessment in an interview with EuroNews: “Our evaluation was a review of all the published scientific literature on glyphosate and this was done by the world’s best experts on the topic that, in addition, don’t have any conflicts of interest that could bias their assessment” (euronews.com/2016/07/01/glyphosate-can-cause-cancer).
Glyphosate’s toxicity is a serious public health concern that has led several European countries, including Italy and France, to call for its complete ban. The U.S.’s EPA hearings related to whether or not glyphosate causes cancer have been delayed and also directly altered by the pesticide trade group CropLife America, which represents Monsanto and other pesticide companies. CropLife tried to get the hearings canceled altogether, lobbied to alter the list of expert included scientists, and successfully pressured the EPA to remove experienced epidemiologist Dr. Peter Infante from the panel without explanation. Infante has spent decades determining the cancer risks of chemicals with organizations such as the Occupational Safety and Health Administration, the EPA, and the World Trade Organization and he will still be speaking during the public commentary.
The EPA has thus far disregarded dozens of independent animal and human studies showing that Roundup® causes cancer. Instead, they have succumbed to industry influence and relied on Monsanto’s interpretation of relevant rodent studies. An independent review of the rodent studies shows that, “the mouse data also demonstrate that glyphosate can induce malignant lymphoma,” and that, “this is clearly sufficient evidence of the carcinogenicity of glyphosate in mice” (regulations.gov/document?D=EPA-HQ-OPP-2016-0385-0371). The Hill shares that over 90 scientists collaborated to identify the research proving glyphosate’s carcinogenic properties, specifically: the growth of tumors in laboratory animals and the connection between glyphosate and non-Hodgkin lymphoma (thehill.com/blogs/pundits-blog/healthcare/309971-serious-scrutiny-needed-as-epa-seeks-input-on-cancer-ties-to). The Miller Firm has filed multiple lawsuits in several state and federal courts seeking to hold Monsanto accountable for its scientific fraud relating to glyphosate, which caused thousands to develop non-Hodgkin’s Lymphoma.
The Miller Firm is presently accepting clients who developed non-Hodgkin’s Lymphoma after using Monsanto’s Roundup® herbicide containing glyphosate. If this has happened to you, please visit our Roundup Lawsuit page today for a free consultation. You can also call us at 1-800-882-2525.
